Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | PPOX | P50336 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22397032 | 0.60 | ATM (0.48) | ALDH1A1ATMLMNAKMT2A | |
| SCHEMBL28926885 | 0.59 | CYP1A2 (0.45) | ALDH1A1LMNAMEN1CYP1A2CYP2C19 | |
| SCHEMBL29617345 | 0.59 | CYP1A2 (0.45) | ALDH1A1LMNAMEN1CYP1A2CYP2C19 | |
| SCHEMBL25577858 | 0.58 | L3MBTL1 (0.54) | ALDH1A1PPOXLMNAMEN1TP53 | |
| SCHEMBL5208842 | 0.58 | L3MBTL1 (0.54) | ALDH1A1PPOXLMNAMEN1TP53 | |
| SCHEMBL25577860 | 0.58 | L3MBTL1 (0.54) | ALDH1A1PPOXLMNAMEN1TP53 | |
| SCHEMBL6904784 | 0.56 | RORC (0.44) | ALDH1A1LMNAMEN1TP53CYP1A2 | |
| SCHEMBL28715952 | 0.56 | TRPM8 (0.35) | ALDH1A1MEN1CYP3A4CYP2C19KMT2A | |
| SCHEMBL809417 | 0.56 | CYP2D6 (0.42) | ALDH1A1ATMLMNACYP3A4CYP2C19 | |
| SCHEMBL11815677 | 0.56 | ALDH1A1 (0.43) | ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230227437-A1 | IMMUNOMODULATOR | HITGEN INC (CN) | 2023-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230227437-A1 | IMMUNOMODULATOR | IL17A, IL2, IL2RA | ALDH1A1 261/4885ATM 4356/4885PPOX 2713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.